We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
4 result(s) found, displaying 1 to 4
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BRUKINSA zanubrutinib 160 mg tablet bottle.
-
Jul-2025Prescription medicine evaluationActive ingredient: tislelizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BRUKINSA zanubrutinib 80 mg capsule bottle.